Wolff Stefani
- SEC CIK
- 0001751790
No open-market purchases or sales filed in the past year.
Current role at each company
- Rain Oncology Inc.Directoras of Jan 26, 2024
- NRIX Nurix Therapeutics, Inc.EVP and COOas of May 2, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Wolff Stefani as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NRIX Nurix Therapeutics, Inc.
EVP and COO5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 2, 2023 (view filing) | May 1 | 1 day | Wolff StefaniEVP and COO | SSale | −342 | $9.88 | −$3.38K | −5.3%6.11K after | |
| Feb 1, 2023 (view filing) | Jan 30 | 2 days | Wolff StefaniEVP and COO | SSale | −424 | $11.78 | −$4.99K | −9.7%3.94K after | |
| Nov 1, 2022 (view filing) | Oct 31 | 1 day | Wolff StefaniEVP and COO | SSale | −350 | $12.88 | −$4.51K | −9.3%3.40K after | |
| Aug 2, 2022 (view filing) | Aug 1 | 1 day | Wolff StefaniEVP and COO | SSale | −356 | $15.67 | −$5.58K | −22.3%1.24K after | |
| May 3, 2022 (view filing) | May 2 | 1 day | Wolff StefaniEVP and COO | SSale | −330 | $11.75 | −$3.88K | −34.3%632 after |